Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Graft hyporeactivity induced by donor-specific bone marrow

M E Rigney1, M R Gignac, H A Gritsch

  • 1Meegan Lynch Hickey Lab for Life, Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania, USA.

Transplantation
|December 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney transplantation utilizing a horseshoe kidney.

Kidney international·2019
Same author

Expression of Mitochondrial-Encoded Genes in Blood Differentiate Acute Renal Allograft Rejection.

Frontiers in medicine·2017
Same author

Broken Chains and Reneging: A Review of 1748 Kidney Paired Donation Transplants.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

A High-Resolution Tile-Based Approach for Classifying Biological Regions in Whole-Slide Histopathological Images.

IFMBE proceedings·2016
Same author

Radiation hazards of primary cosmic particles.

AFMDC TR. Air Force Missile Development Center (U.S.)·2014
Same author

Allograft outcomes in outbred mice.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Donor cell administration, specifically donor-specific bone marrow (DSBM) infusion, significantly reduces immune rejection in organ transplantation by impairing T-cell activity. This method shows effectiveness when administered before or on the day of transplantation, but not after.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Cell Therapy

Background:

  • Organ transplantation aims to improve graft survival through various strategies.
  • The role of donor cell administration in inducing donor-specific hyporeactivity remains unclear.
  • Understanding intra-graft events post-donor cell infusion is crucial for optimizing transplant outcomes.

Purpose of the Study:

  • To investigate whether donor-specific bone marrow (DSBM) infusion confers donor-specific hyporeactivity.
  • To examine the intra-graft immune events following DSBM administration in a murine allograft model.

Main Methods:

  • Utilized an in vivo sponge matrix allograft model in C57BL/6J mice.
  • Administered syngeneic or allogeneic bone marrow (BM) cells intravenously.

Related Experiment Videos

  • Assessed graft-infiltrating cells for in vitro cytotoxicity using 51Cr release assay.
  • Analyzed cell populations (CD4+, CD8+) via flow cytometry.

    • Main Results:

    • DSBM infusion significantly reduced intragraft allospecific cytolytic T-cell (CTL) activity compared to controls.
    • Impaired CTL activity was observed when DSBM was given up to the day of allograft placement (day 0).
    • DSBM led to a decreased percentage of intragraft CD8+ cells, correlating with reduced CTL activity.

    Conclusions:

    • DSBM administration effectively inhibits allospecific CTL development within the allograft.
    • The timing of DSBM administration is critical, with pre-transplant or same-day infusion being most effective.
    • DSBM may induce graft hyporeactivity by suppressing intragraft immune activation, particularly CD8+ T-cell responses.